Thanks for posting this, Wayne, lots of interesting information there.
OldenSlow said
Mar 26, 2014
From the American Chemical Society:
"The progress in HCV therapy in the last three years is similar to the progress that took HIV therapy ~14 years. We are at the brink of approval for an all-oral drug combination that is dosed once daily as a single pill, has >95% efficacy, and is well tolerated. This article summarizes the path to this success and the challenges still ahead."
Hi Wayne,
Good article. Nice to reminise. Cheers.
Thanks for posting this, Wayne, lots of interesting information there.
From the American Chemical Society:
"The progress in HCV therapy in the last three years is similar to the progress that took HIV therapy ~14 years. We are at the brink of approval for an all-oral drug combination that is dosed once daily as a single pill, has >95% efficacy, and is well tolerated. This article summarizes the path to this success and the challenges still ahead."
http://pubs.acs.org/doi/ipdf/10.1021/ml500070q